AR and benign prostatic hyperplasia: In the BPH groups, the levels of testosterone, 5α-reductase, DHT, and AR were all substantially upregulated (Fig. 7a-e), resulting in substantially increased PSA levels (Fig. 7f), a phenomenon being consistent with the manifestations usually seen in the clinical treatment of BPH.